India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032
Overview
The India Acute Respiratory Distress Syndrome (ARDS) Treatment Market is expected to reach a 327.59 USD Million by 2032 and is projected to grow at a CAGR of 16.66% from 2025 to 2032.
Revenue, 2024 (USD Million)
131.33
Forecast, 2032 (USD Million)
327.59
CAGR, 2024 - 2032
16.66%
Report Coverage
India
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market 2018-2032 USD Million
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 131.33 USD Million
- Projected Market Size (2032): 327.59 USD Million
- CAGR (2025-2032): 16.66%
Key Findings of India Acute Respiratory Distress Syndrome (ARDS) Treatment Market
- The India Acute Respiratory Distress Syndrome (ARDS) Treatment Market was valued at 131.33 USD Million in 2024.
- The India Acute Respiratory Distress Syndrome (ARDS) Treatment Market is likely to grow at a CAGR of 16.66% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Parenteral in Route of Administration Segment accounted for the largest share of the market with a revenue of 93.79 USD Million
- The fastest growing segment Mechanical Ventilation in Type Segment grew Fastest with a CAGR of 17.58% during the forecast period from 2024 to 2032.
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market Scope
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market Segmentation & Scope
Type
- Others
- Tocilizumab
- Extracorporeal Membrane Oxygenation (ECMO)
- Antiviral Medication
- Corticosteroids
- Mechanical Ventilation
Cause
- Others
- Severe Pneumonia
- Inhalation of Harmful Substances
- Sepsis
Route of Administration
- Others
- Oral
- Parenteral
End User
- Others
- Home Healthcare
- Specialty Clinics
- Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
- Direct Tender
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 131.33 USD Million |
| Market Value in 2032 | 327.59 USD Million |
| CAGR (2025-2032) | 16.66% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Cause ,Route of Administration ,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): India, leading in terms of revenue 131.33 USD Million in 2024
- Key Country: India, leading in terms of revenue with value of 131.33 USD Million in 2024.
Segments and Scope
-
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Type
- Mechanical Ventilation is the largest segment in India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 58.75 USD Million in the year 2024.
- Mechanical Ventilation is the Fastest growing segment in India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 17.58 % in forecast period 2025-2032.
-
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Cause
- Sepsis is the largest segment in India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 74.15 USD Million in the year 2024.
- Inhalation of Harmful Substances is the Fastest growing segment in India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 17.16 % in forecast period 2025-2032.
-
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Route of Administration
- Parenteral is the largest segment in India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 93.79 USD Million in the year 2024.
- Parenteral is the Fastest growing segment in India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 17.16 % in forecast period 2025-2032.
-
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By End User
- Hospitals is the largest segment in India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 88.87 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 16.96 % in forecast period 2025-2032.
-
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a revenue of 71.46 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in India Acute Respiratory Distress Syndrome (ARDS) Treatment Market to 2032 with a Growth rate of 17.50 % in forecast period 2025-2032.
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Share Analysis
| Company Name |
|
||
| Medtronic | |||
| LivaNova | |||
| Terumo Corporation | |||
| Getinge AB | |||
| Gilead Sciences, Inc. | |||
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The India Acute Respiratory Distress Syndrome (ARDS) Treatment Market is segmented based on Segmentation Type,Cause ,Route of Administration ,End User,Distribution Channel.
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market was valued at USD 131.33(Revenue in USD Million) in 2021.
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market is projected to grow at a CAGR of 16.66% during the forecast period of 2024 to 2032.
The Parenteral segment is expected to dominate the India Acute Respiratory Distress Syndrome (ARDS) Treatment Market, holding a largest market share of 93.79 USD Million in 2024
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market Scope
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market Segmentation & Scope
Type
- Others
- Tocilizumab
- Extracorporeal Membrane Oxygenation (ECMO)
- Antiviral Medication
- Corticosteroids
- Mechanical Ventilation
Cause
- Others
- Severe Pneumonia
- Inhalation of Harmful Substances
- Sepsis
Route of Administration
- Others
- Oral
- Parenteral
End User
- Others
- Home Healthcare
- Specialty Clinics
- Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
- Direct Tender
Frequently Asked Questions
The India Acute Respiratory Distress Syndrome (ARDS) Treatment Market is segmented based on Segmentation Type,Cause ,Route of Administration ,End User,Distribution Channel.
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market was valued at USD 131.33(Revenue in USD Million) in 2021.
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market is projected to grow at a CAGR of 16.66% during the forecast period of 2024 to 2032.
The estimated market value of the India Acute Respiratory Distress Syndrome (ARDS) Treatment Market for final year is USD 327.59 (USD Million).
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market Company Profiling
Frequently Asked Questions
The India Acute Respiratory Distress Syndrome (ARDS) Treatment Market is segmented based on Segmentation Type,Cause ,Route of Administration ,End User,Distribution Channel.
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market was valued at USD 131.33(Revenue in USD Million) in 2021.
India Acute Respiratory Distress Syndrome (ARDS) Treatment Market is projected to grow at a CAGR of 16.66% during the forecast period of 2024 to 2032.
The estimated market value of the India Acute Respiratory Distress Syndrome (ARDS) Treatment Market for final year is USD 327.59 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.